Bedrocan at CPhI Worldwide 2022

A pioneer in the medicinal cannabis industry, Bedrocan began its journey more than three decades ago. We have been a reliable supplier of pharmaceutical-grade medicinal cannabis to the medicinal cannabis programme in the Netherlands  since its inception in 2003.

Through our expertise in the medicinal cannabis space, we strive to create and be part of robust supply chains for cannabis-based medicinal products.

Product offering

Bedrocan currently offers five different strains of dried cannabis flowers, with the Bedrocan product accounting for almost 80% of our total production. Each variety shows a constant composition of cannabinoids (THC & CBD) and terpenes; batch-to-batch, year after year. All our products are produced in accordance with pharmaceutical quality requirements, because our production sites comply with the requirements imposed by EU GMP.

API & raw materials

There is a growing demand for high-quality raw material and APIs to develop cannabis-based medicinal products and through our extensive experience in cultivation of cannabis, stable genetics and quality management system, we are well-positioned to meet this demand.

Clinical research

To complement our cannabis plant and analytical research, we support clinical trials and offer our resources and experience to medicinal cannabis research projects worldwide. For more information on clinical research done with Bedrocan products, please contact Dr. Mikael Kowal at the Meet Bedrocan page.

Reference works

Please download our corporate brochure and the informative booklet A primer to medicinal cannabis at the Downloads page.

Subscribe to newsletter

Finally, maybe you want to stay informed about the developments within Bedrocan?

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.

Start typing and press Enter to search

Legalisation adult-use cannabis in Germany
cannabis use in PTSD